Commentary: resolving pertussis resurgence and vaccine immunity using mathematical transmission models

JOURNAL ARTICLE published 4 March 2019 in Human Vaccines & Immunotherapeutics

Research funded by National Institute of General Medical Sciences (U54-GM111274) | National Institutes of Health (1R01AI101155)

Authors: M. Domenech de Cellès | A. A. King | P. Rohani

Human transcriptome response to immunization with live-attenuated Venezuelan equine encephalitis virus vaccine (TC-83): Analysis of whole blood

JOURNAL ARTICLE published 2 January 2017 in Human Vaccines & Immunotherapeutics

Authors: Rebecca A. Erwin-Cohen | Aimee I. Porter | Phillip R. Pittman | Cynthia A. Rossi | Luis DaSilva

Immunogenicity and safety of the diphtheria, pertussis, tetanus and inactivated poliovirus vaccine when co-administered with the human rotavirus vaccine (Rotarix) in healthy Japanese infants: a phase IV randomized study

JOURNAL ARTICLE published 3 April 2019 in Human Vaccines & Immunotherapeutics

Authors: Paul Gillard | Tsuyoshi Tamura | Haruo Kuroki | Yoshiyuki Morikawa | Leentje Moerman | Jose Parra | Yurina Kitamura | Kazuko Mihara | Arisa Okamasa

Vaccine for the mind

JOURNAL ARTICLE published 16 October 2012 in Human Vaccines & Immunotherapeutics

Authors: Michal Schwartz | Kuti Baruch

The regulatory T cells in anti-influenza antibody response post influenza vaccination

JOURNAL ARTICLE published 16 September 2012 in Human Vaccines & Immunotherapeutics

Authors: Shih-Min Wang | Ming-Hsun Tsai | Huan-Yao Lei | Jen-Ren Wang | Ching-Chuan Liu

The promise and challenge of epitope-focused vaccines

JOURNAL ARTICLE published 2 August 2016 in Human Vaccines & Immunotherapeutics

Authors: Jon Oscherwitz

Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study

JOURNAL ARTICLE published 3 August 2018 in Human Vaccines & Immunotherapeutics

Authors: Martina Kovac | Lusiné Kostanyan | Narcisa Mesaros | Sherine Kuriyakose | Meera Varman

A critical appraisal of ‘Shingrix’, a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus

JOURNAL ARTICLE published 3 August 2017 in Human Vaccines & Immunotherapeutics

Authors: Tehmina Bharucha | Damien Ming | Judith Breuer

Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B

JOURNAL ARTICLE published 4 March 2019 in Human Vaccines & Immunotherapeutics

Authors: Dan-Yang Shi | Bo-Yang Chen | Yun-Yun Mao | Guo Zhou | Jian-Sheng Lu | Yun-Zhou Yu | Xiao-Wei Zhou | Zhi-Wei Sun

Designing around patents with an immunotherapy case

JOURNAL ARTICLE published May 2012 in Human Vaccines & Immunotherapeutics

Authors: Shyh-Jen Wang

Post-marketing surveillance study to assess the safety and tolerability of an Inactivated Poliomyelitis Vaccine in Indian children

JOURNAL ARTICLE published 2 November 2017 in Human Vaccines & Immunotherapeutics

Authors: Hitt Sharma | Rajeev Dhere | Sameer Parekh | Sunil Shewale

Antibody persistence after a single dose of quadrivalent HPV vaccine and the effect of a dose of nonavalent vaccine given 3-8 years later – an exploratory study

JOURNAL ARTICLE published February 2019 in Human Vaccines & Immunotherapeutics

Authors: Vladimir Gilca | Chantal Sauvageau | Gitika Panicker | Gaston De Serres | Manale Ouakki | Elizabeth R. Unger

Effectiveness of 2012–2013 influenza vaccine against influenza-like illness in general population

JOURNAL ARTICLE published March 2014 in Human Vaccines & Immunotherapeutics

Authors: Marion Debin | Vittoria Colizza | Thierry Blanchon | Thomas Hanslik | Clement Turbelin | Alessandra Falchi

A universal infant rotavirus vaccine program in two delivery models: Effectiveness and adverse events following immunization

JOURNAL ARTICLE published 3 April 2015 in Human Vaccines & Immunotherapeutics

Authors: Carolyn Sanford | Joanne M Langley | Scott A Halperin | Mitchell Zelman | MURVP Maritime Universal Rotavirus Vaccin

A 2013/2014 northern hemisphere season surface antigen inactivated trivalent influenza vaccine - Assessing the immunogenicity and safety in an open label, uncontrolled study

JOURNAL ARTICLE published 3 October 2015 in Human Vaccines & Immunotherapeutics

Authors: Louise Roggelin | Christof D Vinnemeier | Seetha Meyer | Kai Witte | Lydia Marx | Wiebke Theeß | Gerd D Burchard | Thierry Rolling | Jakob P Cramer

Alzheimer disease immunotherapeutics: Then and now

JOURNAL ARTICLE published 1 September 2014 in Human vaccines & immunotherapeutics

Authors: Harashish Jindal | Bhumika Bhatt | Shashikantha SK | Jagbir Singh Malik

Comparison of virulence between theYersinia pestis Microtus201, an avirulent strain to humans, and the vaccine strain EV in rhesus macaques,Macaca mulatta

JOURNAL ARTICLE published 2 December 2014 in Human Vaccines & Immunotherapeutics

Authors: Guang Tian | Zhizhen Qi | Yefeng Qiu | Xiaohong Wu | Qingwen Zhang | Xiaoyan Yang | Youquan Xin | Jian He | Yujing Bi | Qiong Wang | Jiyuan Zhou | Yanxiao Fan | Yazhou Zhou | Yongqiang Jiang | Ruifu Yang | Xiaoyi Wang

Building bridges between the public and private sectors

JOURNAL ARTICLE published February 2012 in Human Vaccines & Immunotherapeutics

Authors: Clement Lewin

Telephone monitoring of adverse events during an MF59^®-adjuvanted H5N1 influenza vaccination campaign in Taiwan

JOURNAL ARTICLE published January 2014 in Human Vaccines & Immunotherapeutics

Authors: Wan-Ting Huang | Chih-Hsi Chang | Mei-Chen Peng

Report from the field

JOURNAL ARTICLE published 13 July 2013 in Human Vaccines & Immunotherapeutics

Authors: Denice Spero | Lauren Levitz